TORNTPHARMBSETorrent Pharmaceuticals LtdMinimalNeutral
Announced Mon, 11 May · 21:16 IST

Newspaper cuttings of advertisement published - Notice of Hearing of Petition

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-4.4%1-day move
₹4518.00
prior close
₹4509.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.6-1.7-1.9-1.5-4.4-2.5-3.0-2.5-1.5-1.0-3.3+1.3+9.5
Up moveDown movePending
AI summary

Torrent Pharmaceuticals has disclosed a notice of hearing for the Scheme of Amalgamation involving J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) as the transferor company and Torrent Pharmaceuticals as the transferee company. The hearing is scheduled for June 11, 2026 before the National Company Law Tribunal (NCLT) Bench at Ahmedabad under Sections 230-232 of the Companies Act, 2013. This is a formal legal proceeding where the NCLT will consider sanctioning the merger scheme. Any person wishing to support or oppose the petition must submit an affidavit at least two days before the hearing date and appear before the Tribunal.

Likely market impact

This is a significant step in the regulatory approval process for the JB Pharma acquisition. The NCLT hearing scheduled for June 2026 indicates the merger is progressing through the required legal stages. Successful sanctioning by the Tribunal would complete a major consolidation in the pharmaceutical sector.